| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ART
|
3,975.00 | 2.1B | 1.80 | 1.04 | 0.89 | 19.1% | 20.1% | 76 | 43 | 6,681.85 | +49.0% | 86 | 0.06 |
|
BCF
|
1,392.00 | 952.7M | 1.82 | 1.04 | 0.96 | 17.1% | 22.7% | 69 | 33 | 2,299.91 | +47.0% | 86 | 0.01 |
|
MTA
|
497.00 | 974.3M | — | 0.44 | 0.82 | 9.4% | 10.2% | 68 | 66 | 912.27 | +61.8% | 60 | 2.49 |
|
BEL
|
4,100.00 | 3.9B | — | 1.07 | 1.00 | 16.6% | 18.4% | 54 | 36 | 3,986.96 | -1.8% | 82 | 0.25 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.